Siewert Type I Adenocarcinoma of Esophagogastric Junction
3 clinical trials · Condition
◉ Watch Siewert Type I Adenocarcinoma of Esophagogastric Junction
| Record | Firm | Date |
|---|---|---|
| Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma (NCT06044311) | Melissa Lumish | 2024-09-30 |
| Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery (NCT06277921) | P. Herzen Moscow Oncology Research Institute | 2024-03-18 |
| Classification of Adenocarcinoma of the Esophagogastric Junction (NCT04151524) | St. James's Hospital, Ireland | 2019-10-23 |
Track Siewert Type I Adenocarcinoma of Esophagogastric Junction automatically
Every clearance here is in the API, with alerts when new ones post.